BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3747744)

  • 1. Hepatitis B virus infection in porphyria cutanea tarda.
    Rocchi E; Gibertini P; Cassanelli M; Pietrangelo A; Jensen J; Ventura E
    Liver; 1986 Jun; 6(3):153-7. PubMed ID: 3747744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.
    Rocchi E; Gibertini P; Cassanelli M; Pietrangelo A; Borghi A; Ventura E
    J Lab Clin Med; 1986 Jan; 107(1):36-42. PubMed ID: 3941293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HLA studies and histochemical detection of liver iron in porphyria cutanea tarda].
    Köstler E; Riedel H; Gebhardt B
    Z Hautkr; 1989 Feb; 64(2):132-4. PubMed ID: 2785735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic hepatic porphyria and hepatitis B and C virus infections].
    Malina L; Stránský J; Havlícková M; Zd'árský E
    Cas Lek Cesk; 1998 Sep; 137(18):561-4. PubMed ID: 9818466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Occurrence of HBs-antigen and anti-HBs in patients with porphyria cutanea tarda (author's transl)].
    Goerz G; Uthemann H; Lissner R
    Z Gastroenterol; 1979 May; 17(5):296-300. PubMed ID: 463171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors.
    Salata H; Cortés JM; Enríquez de Salamanca R; Oliva H; Castro A; Kusak E; Carreño V; Hernandez Guío C
    J Hepatol; 1985; 1(5):477-87. PubMed ID: 2997323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.
    Fargion S; Piperno A; Cappellini MD; Sampietro M; Fracanzani AL; Romano R; Caldarelli R; Marcelli R; Vecchi L; Fiorelli G
    Hepatology; 1992 Dec; 16(6):1322-6. PubMed ID: 1359994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda.
    DeCastro M; Sánchez J; Herrera JF; Cháves A; Durán R; García-Buey L; García-Monzón C; Sequí J; Moreno-Otero R
    Hepatology; 1993 Apr; 17(4):551-7. PubMed ID: 7682979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda in Ethiopia.
    Tsega E; Besrat A; Landells JW; Seyoum E
    Trans R Soc Trop Med Hyg; 1981; 75(2):201-6. PubMed ID: 7303133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serologic hepatitis B markers in porphyria cutanea tarda (author's transl)].
    Uthemann H; Kotitschke R; Lissner R; Goerz G
    Dtsch Med Wochenschr; 1980 Dec; 105(49):1718-20. PubMed ID: 6777137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus antigen and antibodies in alcoholics. Etiological role of HBV in liver diseases of alcoholic patients.
    Inoue K; Kojima T; Koyata H; Matsui S; Aoyama K; Konda T; Ichida T; Sasaki H
    Liver; 1985 Oct; 5(5):247-52. PubMed ID: 4079664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of blood ferritin in the evaluation of hepatic siderosis in patients with porphyria cutanea tarda].
    Vozza A; Rossi A; Cicala G; Caso R; Esposito P
    G Ital Dermatol Venereol; 1988; 123(7-8):325-7. PubMed ID: 3224995
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrastructural study of the liver in hepatic prophyria.
    Jean G; Lambertenghi G; Ranzi T
    J Clin Pathol; 1968 Jul; 21(4):501-7. PubMed ID: 5697352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda and human immunodeficiency virus infection.
    Blauvelt A; Harris HR; Hogan DJ; Jimenez-Acosta F; Ponce I; Pardo RJ
    Int J Dermatol; 1992 Jul; 31(7):474-9. PubMed ID: 1500237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyria cutanea tarda in beta-thalassemia trait carriers.
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Ventura E
    Dermatologica; 1984; 169(3):131-4. PubMed ID: 6479421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study.
    Navas S; Bosch O; Castillo I; Marriott E; Carreño V
    Hepatology; 1995 Feb; 21(2):279-84. PubMed ID: 7843694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of the liver in porphyria cutanea tarda.
    Cortés JM; Oliva H; Paradinas FJ; Hernandez-Guío C
    Histopathology; 1980 Sep; 4(5):471-85. PubMed ID: 6253381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence.
    Siersema PD; ten Kate FJ; Mulder PG; Wilson JH
    Liver; 1992 Apr; 12(2):56-61. PubMed ID: 1320175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.